This public procurement record has 1 release in its history.

Award

04 Nov 2026 at 10:23

Summary of the contracting process

NHS Essex Integrated Care Board commissions specialist fertility treatment for eligible patients across its Essex geographical area. Services cover medical and surgical treatment to restore fertility and assisted conception, including IVF with or without ICSI, frozen embryo transfer, embryo and gamete freezing and storage, sperm retrieval, unstimulated IUI, donor egg or sperm treatment, fertility preservation for patients undergoing cancer treatment, egg donation and specialist transport of stored gametes between providers. Care must follow Human Fertilisation and Embryology Authority requirements and the ICB’s assisted conception commissioning policy. This is a broad clinical service spanning regulated fertility treatment, laboratory and storage capabilities, patient pathways and coordination with other NHS providers. The commissioning body is NHS Essex Integrated Care Board.

The process has reached an intention-to-award stage under Direct Award Process C of the Health Care Services (Provider Selection Regime) Regulations 2023; the notice states that the award was not yet formally made, although OCDS records active awards and contracts. The proposed contract period is 1 April 2027 to 31 March 2028. Seven providers are named: Guy’s and St Thomas’ NHS Foundation Trust, Bourn Hall Clinic, Cambridge University Hospital Foundation Trust, Care Fertility Group Limited, Create Health Limited trading as Create Fertility, Herts & Essex Fertility Centre, and IVI London Wimpole Ltd. Individual planning values are £51,737, £644,727, £13,383, £0, £27,782, £160,414 and £51,560 respectively; contracts are recorded at £1 each, while the service description says payment is at local prices and activity-dependent. Assessment weighted quality and innovation at 40%, value at 30%, integration and sustainability at 15%, access and choice at 10%, and social value at 5%.

This award demonstrates continuing NHS Essex demand for a comprehensive, regulated fertility service delivered by established providers. A credible competitor when this requirement returns would need the clinical and laboratory capacity to deliver the full range of assisted conception and fertility-preservation pathways, including treatment, retrieval, freezing, storage and transfer of gametes or embryos. Strong evidence of safe outcomes and reliable delivery would matter: the assessment emphasised patient safety, live birth rates, waiting-time standards and reducing treatment complications, alongside compliance with HFEA standards, CQC requirements and NICE guidance. Suppliers would also need to demonstrate value for public money, effective coordination with secondary care and other providers, and accessible services that address health inequalities and support patient choice. Innovation is relevant where it improves outcomes, experience, efficiency or access without compromising clinical safety or regulatory compliance; social value also formed part of the assessment.

How relevant is this notice?

Notice Information

Notice Title

DAP C Specialist Fertility Services 27/28

Notice Description

NHS Essex Integrated Care Board (herein "the Authority")'s intention to award contracts to deliver Specialist Fertility Services to the patients within NHS Essex's ICB geographical footprint. The contract will be for 12 months months from 01st April 2027 - 31st March 2028. The aggregate contract values are below inclusive VAT noting that these are zero value contracts - paid at local prices- based on planning values for 2026-27 and will be subject to any agreed growth and inflator/deflators applicable to 2027/28. Cambridge University Hospital FT PS13,383.00 Bourne Hall Fertility PS644,727.00 Care Fertility PS0.00 Create Health Limited t/a Create Fertility PS27,782.00 Guys & St Thomas Hospital PS51,737.00 Herts & Essex Fertility Centre PS160,414.00 IVI London Wimpole Ltd PS51,560.00 The award details for each provider will reflect a nominal PS1.00. The providers are existing providers, who are currently satisfying the requirements of the existing contract. The providers have been assessed against the criteria specified for this DAP C process: Quality & Innovation 40%. Quality should be the primary consideration for specialist fertility services due to the highly regulated nature of assisted conception treatment, the clinical risks associated with fertility interventions and the importance of achieving safe, effective patient outcomes. The service specification places significant emphasis on compliance with Human Fertilisation and Embryology Authority (HFEA) standards, CQC requirements, NICE guidance, patient safety, live birth rates, waiting time standards and reducing avoidable harm such as multiple births and treatment complications. Innovation remains important, particularly in supporting improvements in patient experience, clinical outcomes, efficiency and access to treatment. However, any innovation must operate within established regulatory and clinical frameworks and should not compromise the quality, safety or effectiveness of care. Value 30%. It is a statutory duty to ensure the best use of public resources, therefore value has the second highest weighting Integration, Collaboration & Service Sustainability 15%, It is essential for good collaboration between specialist fertility services and secondary care Access Health Inequalities and Choice 10%; Access to specialist services are important to ensure all patients receive the appropriate care and treatment Social Value 5%. Although the main focus of the specialist fertility service is to provide healthcare, a weighting of 5% has been allocated to reflect the ICB priority towards the importance of social value Key criteria were specified, and assessment against each criterion was assessed based as above and on the current service delivery model and performance. and the supplier meets all the requirements specified to the satisfaction of the ICB, and it is expected that they will satisfy the requirements of the new contract. NHS Essex Integrated Care Board (the Authority) intends to award a contract for the provision of Community Specialist Fertility Services in to the existing providers anmed above following Direct Award Process C under the Health Care Services (Provider Selection Regime) Regulations 2023. NHS Essex Integrated Care Board, acting as the Relevant Authority, is commissioning these services to support will be provided in line with the NHS Essex ICB Service Restriction Policy: Assisted Conception Commissioning Policy. Further details can be found at II.2.4) Description of the procurement

Lot Information

Lot 1

The Authority intends to award this contract via Direct Award Process C under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 and Procurement Act 2023 do not apply. NHS Essex Integrated Care Board is the Relevant Authority undertaking this process. The services comprise the provision of Specialist Fertility Services. Infertility is defined as a failure to conceive after regular unprotected sexual intercourse in the absence of known reproductive pathology. The management of infertility falls into 3 main types: 1. Medical treatment to restore fertility (for example, the use of drugs for ovulation induction) 2. Surgical treatment to restore fertility (for example, laparoscopy for ablation of endometriosis) 3. Assisted reproduction techniques - any treatment that deals with means of conception other than vaginal coitus. It frequently involves the handling of gametes or embryos and mainly includes in vitro fertilisation (IVF), intra-cytoplasmic sperm injection (ICSI), and Donor Insemination (DI). The specialist fertility services to be provided to patients fulfilling the eligibility criteria include: 1. In Vitro Fertilisation (IVF) with or without Intra-cytoplasmic Sperm Injection (ICSI) 2. Frozen Embryo Transfer 3. Embryo/Blastocyst Freezing and Storage (Gametes) 4. Surgical sperm recovery (Testicular Epididymal Sperm Aspiration (TESA) / Percutaneous Sperm Aspiration (PESA) including storage where required) 5. Intrauterine Insemination (IUI) unstimulated 6. Donor Oocyte Cycle 7. Donor Sperm Insemination, with IVF/IUI. Donor insemination in following conditions: obstructive azoospermia, non-obstructive azoospermia, severe deficits in semen quality in couples who do not wish to undergo ICSI, where there is a high risk of transmitting infectious disease to the offspring or woman from the man 8. Oocyte retrieval for patients undergoing cancer treatments - includes first years' storage 9. Oocyte or sperm annual storage for patients undergoing cancer treatment1. 10. Egg donation where no other treatment is available: The patient must be able to provide a donor; alternatively, the patient can be placed on the waiting list until a donor becomes available. This waiting list will be monitored separately to the general IVF waiting list. 11. Specialist courier transportation of stored gametes between NHS providers where an eligible patient chooses to transfer their NHS treatment. This will also apply to patients choosing to transfer from a private clinic to NHS clinic in order to comply with the MSE ICB policy. The above services shall be provided in line with HFEA regulations The providers are existing providers of these services to NHS Essex Integrated Care Board and has demonstrated their ability to deliver the services to the required standard, following assessment against the five key Provider Selection Regime criteria. The contract period is from 01 April 2027 to 31 March 2028. The total contract value for the 2027/28 is PS0 and the indicative aggregate value are as previously stated. The value is activity-dependent and may vary over the contract term. The proposed values for the term are shown II.1.4. These are zero value contracts - paid at local prices- based on planning values for 2026-27 and will be subject to any agreed growth and inflator/deflators applicable to 2027/28.

Procurement Information

This is a Direct Award Process C intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For avoidance of doubt, the provisions of the Public Contract Regulations 2015 and Procurement Act do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by midnight Tuesday, 17 November 2026. The contract has not yet formally been awarded, this notice serves as an intention to award under PSR. The Authority has undertaken an appropriate and proportionate review of declarations and is satisfied that effective arrangements are in place to identify and manage any actual, potential, or perceived conflicts of interest. Where relevant, mitigation measures have been applied to ensure that no conflict is capable of conferring any undue advantage or disadvantage. On this basis, the Authority is satisfied that no conflict of interest has adversely affected, or is capable of adversely affecting, the integrity of the procurement. On this basis, the Authority is satisfied that no conflict of interest has adversely affected, or is capable of a] All five key criteria were utilised in determining the suitability and continuation of the provider. The criteria were applied as per below, comprising: Quality and Innovation (40%) - Quality should be the primary consideration for specialist fertility services due to the highly regulated nature of assisted conception treatment, the clinical risks associated with fertility interventions and the importance of achieving safe, effective patient outcomes. The service specification places significant emphasis on compliance with Human Fertilisation and Embryology Authority (HFEA) standards, CQC requirements, NICE guidance, patient safety, live birth rates, waiting time standards and reducing avoidable harm such as multiple births and treatment complication Value (30%) - It is a statutory duty to ensure the best use of public resources, therefore value has the second highest weighting Integration, Collaboration and Service Sustainability (15%) -It is essential for good collaboration between specialist fertility services and secondary care Improving Access, Reducing Health Inequalities and Facilitating Choice (10%) - Access to specialist services are important to ensure all patients receive the appropriate care and treatment Social Value (5%) -Although the main focus of the specialist fertility service is to provide healthcare, a weighting of 5% has been allocated to reflect the ICB priority towards the importance of social value

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-07b295
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/104531-2026
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Limited
Procurement Method Details
Award procedure without prior publication of a call for competition
Tender Suitability
Not specified
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

85 - Health and social work services


CPV Codes

85100000 - Health services

85111310 - In vitro fertilisation services

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£1

Notice Dates

Publication Date
4 Nov 20261 weeks ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS Essex Integrated Care Board
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
CHELMSFORD
Postcode
CM1 1QH
Postcode Area
Chelmsford
Country
England

Major Region (ITL 1)
TLH East (England)
Basic Region (ITL 2)
TLH3 Essex
Small Region (ITL 3)
TLH36 Heart of Essex
Delivery Location
TLH3 Essex

Local Authority
Chelmsford
Electoral Ward
Moulsham and Central
Westminster Constituency
Chelmsford

Supplier Information

Number of Suppliers
7
Supplier Names

Guy's and St Thomas' NHS Foundation Trust

Bourn Hall Clinic

Cambridge University Hospital Foundation Trust

Care Fertility Group

Create Health Ltd

HERTS and ESSEX FERTILITY CENTRE LIMITED

IVI London Wimpole Ltd

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...